Navigation Links
Central Florida Pain Relief Expert Dr. Avi Bhandary Gives Patients Their Life Back with BOTOX®
Date:5/29/2013

Orlando, FL (PRWEB) May 29, 2013

Dr. Avi Bhandary of Rehabilitation Medical Group, a leading comprehensive pain management practice in Central Florida, is giving patients their life back through the FDA-approved use of BOTOX® (Botulinum toxin A) as a preventative treatment for chronic migraines.

Sharon and Meghan McGinnis have suffered from chronic migraines for most of their lives. The mother and daughter said they have tried nearly everything for relief, but only one thing has worked for them – BOTOX®. “This finally gave us our life back,” Meghan McGinnis said. “We’ve been telling anybody that has migraines, ‘You’ve got to go try this.’”

The Food and Drug Administration approved BOTOX® injections for migraine treatment in 2010, after clinical studies funded by Allergan, Inc. produced evidence that patients showed improvement in incidence of chronic migraines for migraine sufferers receiving the BOTOX® treatment. Several trials since have shown Botulinum toxin A improves headache symptoms and quality of life when used as a preventative treatment for migraines.

“When you can promise a patient who has suffered with chronic migraines headache-free days, that's something that means a lot to them,” Bhandary said. Patients suffering from chronic migraines experience symptoms including light-sensitivity, nausea and vomiting, blurred vision or vision loss, and pulsating or throbbing pain. For some patients these symptoms, and the chronic nature of their migraines, are so severe that daily activities such as working become difficult, if not impossible.

Migraine treatment options include pain-relieving prescription medications from Triptans such as Imitrex®, to anti-nausea medications and opiates. These medications are designed to treat the symptoms of migraines, and though effective, often come with side effects that pose problems for patients longer-term. “BOTOX relaxes the muscles and reduces contractions, stopping migraines before they start,” Dr. Bhandary said. “For some patients, this is a quality of life they never knew was possible.”

For migraine patient Meghan McGinnis, “This is different - this is what normal feels like.” Dr. Bhandary’s insight, clinical skill, and knowledge of the use of Botulinum toxin A for the therapeutic treatment of chronic migraines, is giving migraine patients in Central Florida new hope.

About Dr. Bhandary:
Dr. Avi Bhandary is an award-winning physician who joined Dr. Michael Creamer, one of Orlando’s most experienced interventional physicians, at Rehabilitation Medical Group (RMG) in 2012. Dr. Bhandary’s extensive experience with Botulinum toxin A is a result of his training at the University of Pittsburgh, working with stroke related spasticity and children afflicted with Cerebral Palsy. Patients can see Dr. Bhandary at Rehabilitation Medical Group to evaluate headache symptoms, assess and potentially rule out possible underlying factors such as cervical spine disorders, and receive expert opinion on the safety and efficacy of Botulinum toxin A for the treatment of migraines and spasticity. Rehabilitation Medical Group physicians hold certifications in the field of Pain Medicine, as well as Physical Medicine and Rehabilitation. RMG provides patients in Central Florida with customized care plans that emphasize independence, comfort and the maintenance of functionality, working to eliminate over-dependence on prescription pain medications.

Read the full story at http://www.prweb.com/releases/BotoxForMigraines/BhandaryRMGOrlando/prweb10768590.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. KORT's Athletic Training Program at Central High School Sends Student to National Health Sciences Competition
2. Preferred retinal location may aid rehabilitation in patients with central vision loss
3. Baldrige Award Winner Southcentral Foundation Selects i2iTracks Population Health Intelligence Solution to Support Meaningful Use, GPRA and UDS Reporting Requirements
4. Hound.com Finds Jobs in South Atlantic and South West Central Regions Mirroring Current Employment Trends
5. Central Oregon Management Consultant Earns TIGERS Success Series Team Development and Team Effectiveness Certification and Licensing
6. Central Marketplace, Inc. Launches Website Featuring AllerAir Air Purifiers
7. Study finds key protein for firing up central nervous system inflammation
8. Online Birkenstock Store BirkenstockCentral.com is offering Life is good® Limited Edition Boston Love Tee Shirt
9. Mom Central Bloggers to Get a Sneak Peak at the New and Improved Adult Essentials Multi Vitamin Gummies
10. Medistra Hospital, Jakarta Becomes First Hospital in Indonesia with Centralized Image Archive
11. WINFertility Treatment Program Expands to Central/Southern Texas. Program Makes IVF Treatment More Affordable for Patients Without Infertility Insurance Coverage.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... ... prescription opioid overdose deaths now claim the lives of 62 Americans each day.(1) ... filings against drug manufacturers, distributors, pharmacies and prescribers by more than half.(2) ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... designed to recognize elevated anxiety levels in people with addiction who are served ... Smart Patch, a biosensing wearable device that monitors heart and breath rates to ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... health of individuals with HIV because it is not known to have significant ... have favorable effects to both lower cholesterol levels and dampen inflammation in the ...
(Date:4/24/2017)... ... ... Come to PAINWeekEnd (PWE) Tampa on May 20 and 21, at the ... 2-day program. , An attendee at a recent PAINWeekEnd said, "Very helpful, wish ... course entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant Behavior, presented by Dr. ...
(Date:4/24/2017)... FOREST KNOLLS, Calif. (PRWEB) , ... April 24, 2017 , ... ... and health topics, but she has not found any of them to be very ... weekly actions to slowly and easily make changes in their health. It prompted her ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Vivify Health, the pioneer ... has been awarded a very significant patent for the ... to continual care via digital health.  This landmark patent ... property and further secures Vivify,s position as the leader ... 2009, was the first company to apply consumer mobile ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... Research and Markets has announced the ... Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies ... ... was valued at US$ 7,167.6 Mn in 2015, and is ... a CAGR of 5.6% from 2016 to 2024. ...
Breaking Medicine Technology: